Merck Biologics Manufacturing Facility
Sector: Commercial • Location: Wilmington, Delaware, United States
Source: townsquaredelaware.com
Merck Sharp & Dohme LLC has proposed a $900 million biologics manufacturing facility in Wilmington, Delaware. The project aims to create 375 jobs and is expected to be fully operational by 2030. The facility will be located at the Chestnut Run Innovation & Science Park and will include multiple buildings for lab operations, production, and warehousing.
Project Information FAQ
Project Information
Want to explore the full details? View the full report
Participants
Sponsoring Agency | Obfuscated Data |
Company | Obfuscated Data |
Status
Original status | planned |
Taiyo status | Obfuscated Data |
Taiyo last update | 00-00-0000 |
Available timestamps | 00-00-0000 |
Available timestamp type | Obfuscated Data |
Contact
Contact name | Obfuscated Data |
Phone | 0000000000 |
ObfuscatedData@email.com | |
Address | Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data |
Description
Description | Merck Sharp & Dohme LLC has proposed a $900 million biologics manufacturing facility in Wilmington, Delaware. The project aims to create 375 jobs and is expected to be fully operational by 2030. The facility will be located at the Chestnut Run Innovation & Science Park and will include multiple buildings for lab operations, production, and warehousing. |
Original sub-sector | Obfuscated |
Original Currency | USD |
Original budget | 000000000000000 |
Procurement method | Obfuscated Data |
Budget | 000000000000000 |
Location
Region | Obfuscated |
Country | Obfuscated |
State | Obfuscated Data |
County | Obfuscated |
Location | Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data |
Source
Source reliability | High |
Data quality score | 100% |
Source | Obfuscated Data |
URL | obfuscated_data,obfuscateddata.com |
More Details
Project Type | Obfuscated Data |
Article Published Date | Obfuscated Data |